Yuani Uppal

Bachelor of Medicine and Bachelor of Science,  CharitĂ© - Universitätsmedizin Berlin 

Location: United States

Consulting Services

Hospital-Pharmacy-Insurance Legal Support

Areas Of Interest

Sulfur Dioxide Monostotic Fibrous Dysplasia Cholinesterase Inhibitors, Irreversible Disorder, LDL Receptor Phaseolus mungo Republic of Niger Melanoma, Harding Passey Signals, Peroxisome Targeting Committees, Clinical Ethics Giardiases Pneumoconiosis Ertapenem Connectionist Model Research, Nontherapeutic Diffusion, Innovation beta Tubulin Whales, Humpback Hyper-IgE Syndrome Mycoplasma synoviae Prolonged-Action Preparation Sciatic Nerves Race, Australian Itchs, Dew Procedures, Minor Surgical Parazone Cornual Pregnancy Giant Cell Fibroblastoma Dasyprocta leporina Physician Payment Review Commissions Sigmoid Colon Disease Pseudoexfoliation Syndrome Pediatric Dentists Islet Cell Adenomas Tissue Adhesive Sturge Weber Syndrome Technetium Tc 99m Aggregated Albumin Receptor, GLP-2

Professional Narrative

Dr. Yuani Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 1997
Senior Director, Mayo Clinic 2008

Education

Doctor of osteopathic medicine, Perelman School of Medicine 1997
Director Medicine, Weill Medical College 2018

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :